Can money help cure cancer stress? new program targets financial toxicity
NCT ID NCT04931251
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a financial navigation program for cancer patients in rural and non-rural North Carolina. The program helped patients find financial assistance to reduce the burden of cancer costs. Researchers measured changes in financial toxicity and quality of life in 258 participants.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Financial navigation program
- What this could lead to
- If successful, this program could provide a model for helping cancer patients manage the financial burden of treatment, reducing stress and improving well-being.
- What could go wrong
- This is a completed study, but results may not apply to all regions or cancer types. The program's effectiveness depends on available resources and patient engagement.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
258 people
The number who actually took part.
- Started
-
Nov 2021
- Finished
-
Jul 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients 18 years of age and older * Patients with any type of cancer diagnosed within 5 years and/or living with advanced disease * Patients who score 22 or lower on the COST measure indicating high FT * Patients must be able to read and speak English Exclusion Criteria: * Participants without a cancer diagnosis * Patients diagnosed more than 5 years ago without advanced disease * Patients or caregivers under the age of 18 * Patients who do not sign the consent form * Patients who do not complete the baseline COST survey * Patients who cannot read and speak English
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Carteret Health Care Cancer Center
Morehead City, North Carolina, 28557, United States
-
NC Basnight Cancer Hospital
Chapel Hill, North Carolina, 27514, United States
-
Novant Health
Charlotte, North Carolina, 28207, United States
-
Pardee UNC Health Care, Pardee Cancer Center
Hendersonville, North Carolina, 28739, United States
-
The Outer Banks Hospital
Nags Head, North Carolina, 27959, United States
-
UNC Lenoir Cancer Care Services
Kinston, North Carolina, 28501, United States
-
Vidant Medical Center, Cancer Center
Greenville, North Carolina, 27834, United States
-
Wake Forest University Health Sciences
Winston-Salem, North Carolina, 27157, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can colorectal surgery patients go home in two days?
- Can a personal navigator help young cancer patients through treatment?
- Can a smartwatch predict which cancer patients return to hospital?
- Two-Drug combo aims to stall advanced breast cancer
- Blood thinner flush could boost tumor biopsy success
- Could a frailty score predict which older cancer patients survive intensive care?